Byron Holloway, DO
Payments from drug & device makers
Across 73 payments — averaging $242.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aroa Biosurgery Incorporated$10K
- Intuitive Surgical$3K
- TELA Bio, Inc.$3K
- Davol Inc.$621
- Smith+Nephew$191
- Heron Therapeutics, Inc.$146
- plus $531 from 11 others
What the payments were for
- Consulting fees$7004%
- Speaking & faculty fees$4,05023%
- Travel & lodging$7,78744%
- Food & beverage$3,18818%
- Education$2,00011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aroa Biosurgery Incorporated | 10 | $10,076 |
| Intuitive Surgical | 13 | $3,361 |
| TELA Bio, Inc. | 17 | $2,799 |
| Davol Inc. | 11 | $621 |
| Smith+Nephew | 3 | $191 |
| Heron Therapeutics, Inc. | 2 | $146 |
| Novo Nordisk | 1 | $123 |
| ETS Wound Care LLC | 2 | $64 |
| Lifenet Health | 2 | $61 |
| Hydrofera LLC | 2 | $56 |
| Conmed Corporation | 2 | $55 |
| KCI USA, Inc. | 2 | $43 |
| Avita Medical Americas, LLC | 1 | $40 |
| Mimedx Group, Inc. | 2 | $30 |
| Solventum Corporation | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Medtronic | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,047
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$1,631
- DAVINCI XI$1,000
- OviTex 2S$871
- GRAFIX PL$135
- STRAVIX PL$135
- Oasis$135
- Phasix Mesh$128
- Wegovy$123
- APONVIE$121
- Zynrelef$121
How this compares
$17,725 in reported general payments places this provider in the 80th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 34 | $115 |
| Methocarbamol | 14 | $67 |
| Tramadol Hcl | 22 | $48 |
Paid to pharmacies, not to this prescriber.
Other surgery in Tampa
- John MullinaxTampa$1.5M
- Amit TaggarTampa$1.4M
- Christopher DucoinTampa$1.1M
- Richard DiciccoTampa$964K
- Salvatore DocimoTampa$950K
- Vic VelanovichTampa$441K
- Sharona RossTampa$271K
- Amod SarnaikTampa$232K
- Vernon SondakTampa$220K
- Adham SaadTampa$167K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.